Working... Menu
Trial record 42 of 181 for:    DCLRE1C

ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03965546
Recruitment Status : Recruiting
First Posted : May 29, 2019
Last Update Posted : August 8, 2019
Eureka Therapeutics Inc.
Information provided by (Responsible Party):
First Affiliated Hospital Xi'an Jiaotong University

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2021
  Estimated Study Completion Date : June 2022